When you are diagnosed with cancer, you may meet several specialists within a short period. A surgeon may discuss an operation, a medical oncologist may recommend chemotherapy, and a radiation oncologist may consider radiation therapy. You may also be advised to undergo another scan, a pathology review, or molecular testing.
One of the most common questions my patients ask is:
“Who brings all these opinions together and decides what treatment I should receive first?”
This is where a tumor board can play an important role.
Cancer treatment should not be planned from a scan, biopsy report, or consultation in isolation. The cancer type, stage, tumor biology, location, general health of the patient, and available treatment options must be examined together.
A tumor board provides a structured way for the relevant specialists to review this information and recommend a coordinated treatment plan.
A tumor board is a formal meeting in which doctors and other healthcare professionals from different areas of cancer care review and discuss individual cancer cases.
It may also be called a “Multidisciplinary tumor board”
The National Cancer Institute defines tumor board review as a treatment-planning process in which cancer doctors and other healthcare specialists meet regularly to discuss new and complex cases and decide, as a group, on the most appropriate treatment plan.
I usually explain it to patients as a clinical roundtable.
The pathologist explains what the biopsy shows. The radiologist reviews the actual scans. The surgical oncologist assesses whether the cancer can be removed safely. The medical oncologist evaluates the role of chemotherapy, targeted therapy, immunotherapy, or hormone therapy. The radiation oncologist considers whether radiation may improve cancer control.
These separate opinions are then brought together into one coordinated recommendation.
A tumor board recommendation is not a treatment order. It does not replace the consultation between you and your treating doctor. It is a multidisciplinary medical opinion based on the information available at that time.
The composition of a cancer treatment team depends on the type of cancer being discussed. A breast cancer tumor board, for example, may include different specialists from a gastrointestinal, thoracic, gynecological, urologic, or head and neck cancer tumor board.
| Tumor board member | Role in cancer treatment planning |
|---|---|
| Surgical oncologist | Evaluates whether the tumor can be removed safely, the extent of surgery required, lymph node management, possible surgical risks, and whether an organ-preserving procedure is appropriate. |
| Medical oncologist | Determines whether chemotherapy, immunotherapy, targeted therapy, or hormone therapy may be needed before or after surgery. |
| Radiation oncologist | Assesses whether radiation therapy is required and whether it should be given before surgery, after surgery, or as the main treatment. |
| Radiologist | Reviews CT, MRI, PET-CT, ultrasound, and other scans to clarify the tumor’s location, extent, involvement of nearby structures, and possible spread. |
| Pathologist | Confirms the diagnosis by examining biopsy or surgical tissue and reports the tumor type, grade, margins, lymph node findings, and relevant biomarkers. |
| Nuclear medicine specialist | Reviews functional and molecular imaging, including PET scans and selected nuclear medicine studies. |
| Organ-specific specialist | A gastroenterologist, pulmonologist, gynecologist, urologist, or another specialist may contribute findings from endoscopy, bronchoscopy, diagnostic procedures, or organ-function tests. |
| Genetic counselor or molecular specialist | Reviews inherited cancer risk, family history, and tumor-related genetic changes that may influence testing, family screening, or treatment. |
| Anesthesiologist or critical care specialist | Assesses whether the patient can safely undergo major surgery and whether additional preparation or postoperative monitoring is required. |
| Palliative and supportive care team | Helps manage pain, symptoms, nutrition, emotional concerns, and quality-of-life needs alongside cancer-directed treatment. |
| Specialist nurse, nutritionist, physiotherapist, or social worker | Supports treatment coordination, nutrition, physical recovery, home care, and practical needs that may affect treatment completion. |
Not every professional attends every meeting. What matters is that the specialists relevant to the cancer type and the clinical question contribute to the discussion.
A tumor board does not look only at the name of the cancer. The team may review:
The biopsy and scans provide different pieces of the clinical picture.
The biopsy identifies the cancer type and may provide information about grade, hormone receptors, biomarkers, or molecular characteristics. The National Cancer Institute’s pathology guidance explains how pathology findings contribute to diagnosis and treatment planning.
Imaging shows where the tumor is located, how far it extends, whether nearby structures are involved, and whether there is evidence of disease elsewhere.
The tumor board connects these findings before recommending treatment.
A well-organized tumor board meeting usually follows a structured process.
The treating doctor summarizes the patient’s symptoms, medical history, diagnosis, general health, and previous treatment.
More importantly, the doctor identifies the question that the team needs to answer. For example:
A clearly defined question makes the tumor board discussion more useful.
The pathologist explains what the biopsy shows, including the cancer type, subtype, and grade. The pathology slides may be reviewed again when the tumor is rare, the biopsy sample is small, or the original diagnosis is uncertain.
Another pathology review may also be needed when the biopsy findings do not match the imaging or clinical behavior of the tumor.
Sometimes the safest tumor board recommendation is to obtain more tissue before beginning treatment.
The radiologist usually reviews the scan images rather than relying only on the written report.
For cancer surgery planning, the team may need to see:
The radiologist may recommend another scan or an image-guided biopsy if a finding could change the treatment plan.
Cancer staging describes the extent of the disease. Depending on the cancer, it may consider the primary tumor, lymph node involvement, and whether the cancer has spread to another part of the body.
Stage is one of the main factors used in cancer treatment decision making. It can influence whether treatment begins with surgery, chemotherapy, radiation therapy, or a combination. The National Cancer Institute’s cancer staging guide provides a patient-friendly explanation of why staging matters.
The team must be clear about what the proposed treatment is intended to achieve. The goal may be:
Two people with cancer in the same organ may receive different recommendations because the stage, tumor biology, general health, and treatment goals are different.
The multidisciplinary team in oncology considers the expected benefits, risks, and limitations of reasonable treatments, which may include:
The team considers not only which treatments are required, but also the order in which they should be given.
The recommendation may be:
The recommendation should be documented and explained to the patient by the treating doctor.
Cancer rarely belongs to only one specialty. Even when surgery is likely to be the main treatment, the decision may depend on imaging, pathology, cancer medicines, radiation therapy, anesthesia, nutrition, and rehabilitation.
A tumor board reduces the risk of treatment being planned from only one professional viewpoint.
This does not mean that an individual specialist cannot make a good decision. It means that complex cancer care may become more coordinated when the relevant experts review the same information together.
An effective treatment plan begins with the correct diagnosis and accurate cancer staging.
If the biopsy suggests one diagnosis but the scans suggest another, the difference must be examined. If a small abnormality on a scan could change the stage, the tumor board may recommend additional imaging or a biopsy before treatment.
Starting treatment with incomplete information can occasionally result in an ineffective sequence or an unnecessarily extensive procedure.
In my clinical experience, this is one of the most valuable functions of a tumor board.
Many patients understandably believe that a visible tumor should be removed immediately. However, surgery is not always the best first treatment.
For selected cancers, chemotherapy before surgery may:
Radiation before surgery may be recommended in selected rectal cancers, soft tissue tumors, and other clinical situations.
In other patients, surgery should be performed first because it provides the most appropriate opportunity for complete removal, prevents a foreseeable complication, or provides tissue needed for accurate pathological staging.
The correct cancer treatment sequence depends on the diagnosis, stage, tumor biology, technical operability, and condition of the patient—not simply on which doctor the patient meets first.
Surgery, radiation therapy, and some systemic treatments can have permanent effects. Before recommending a major operation, a cancer care team may ask:
A multidisciplinary discussion allows these questions to be considered before an irreversible step is taken.
A tumor board may identify an approach that was not discussed during the first consultation, such as:
Research suggests that tumor board review can alter diagnostic interpretations, staging, or management recommendations in some cases. However, the effect varies among cancer types and healthcare settings. It should be viewed as a method of improving coordination and decision quality—not as a guarantee of a better outcome. This distinction is also emphasized in published reviews of multidisciplinary tumor boards.
Undertreatment means that a patient does not receive a treatment that could provide meaningful benefit. Overtreatment means that a patient receives more treatment than necessary without sufficient additional benefit.
For one patient, removing the visible tumor may not be enough, and chemotherapy or radiation may also be required. For another, a very extensive operation may offer little meaningful benefit compared with a less burdensome approach.
Multidisciplinary cancer care helps the team examine both possibilities.
Patients generally do not attend tumor board meetings, but their goals should still influence the discussion.
Before your case is presented, tell your doctor what matters to you. Depending on the cancer, your priorities may include:
A technically possible treatment is not automatically the best treatment for every patient.
The most appropriate plan combines medical evidence and cancer control with safety, general health, personal priorities, and informed choice.
No. Not every cancer patient requires formal tumor board review.
Many straightforward cases can be managed appropriately using established evidence-based guidelines and direct coordination between the relevant doctors.
A tumor board for cancer patients may be especially valuable when:
It may also be helpful when specialized cancer treatment or surgery is not routinely available at every hospital.
Yes. A tumor board can change a cancer treatment plan, although a change is not inevitable.
The board may:
If the recommendation changes, your doctor should explain what new information or clinical reasoning led to the change.
“The tumor board decided” should never be the only explanation given to a patient.
A properly organized tumor board should not normally cause an unnecessary delay.
Many meetings are conducted weekly. A short, purposeful interval used to complete essential scans, verify pathology, or obtain specialist input can prevent treatment from beginning with incomplete information.
Careful planning is not the same as avoidable delay.
However, formal tumor board discussion should not prevent urgent medical care when a patient has a cancer-related complication. The immediate problem must be stabilized, and multidisciplinary review can be expedited or conducted after urgent treatment has begun.
No. A cancer second opinion usually involves another specialist independently reviewing the diagnosis and proposed treatment. A tumor board is a group discussion involving multiple specialties.
The two can complement each other.
A second-opinion specialist may present the case at a multidisciplinary tumor board when:
Seeking a second opinion does not mean that you distrust your doctor. It can be a responsible step before making an important treatment decision.
Before beginning treatment, make sure you understand three things: your confirmed diagnosis and stage, the goal of treatment, and
why the recommended treatment sequence is preferred.
A tumor board is most useful when its recommendation is clearly explained and connected to your individual circumstances.
I advise patients to ask:
Fact: Tumor boards discuss newly diagnosed, complex, rare, and preference-sensitive cases. Being discussed does not automatically mean that the cancer is advanced.
Fact: Some cancers are best treated with surgery first. Others may benefit from chemotherapy or radiation before surgery, and some may not require surgery.
Fact: A well-run tumor board develops its recommendation through relevant specialist input, clinical evidence, guidelines, and respectful discussion.
Fact: You can ask why an option was recommended, discuss reasonable alternatives, and seek another opinion before giving consent.
Fact: New biopsy results, scan findings, treatment response, surgical findings, or changes in health may require the plan to be reconsidered.
It is a multidisciplinary medical opinion about the most appropriate next steps. Your treating doctor should explain the recommendation, alternatives, benefits, and risks before you decide on treatment.
The team reviews the clinical history, biopsy, pathology, scans, cancer stage, general health, treatment goals, and available options before recommending a coordinated treatment sequence.
Participants may include surgical, medical, and radiation oncologists, radiologists, pathologists, organ-specific specialists, genetic experts, nurses, and supportive-care professionals.
Patients do not routinely attend most tumor boards because these are clinical working meetings and may include several confidential cases. Hospital policies may differ.
Yes. It may confirm the existing plan, recommend more testing, revise the stage, change the treatment sequence, or identify another reasonable option.
No. Straightforward cases may be treated according to established guidelines. Formal review is particularly useful for rare, complex, recurrent, uncertain, or preference-sensitive cancers.
Yes. It can be valuable when doctors disagree, surgery is complex, the diagnosis is uncertain, or several treatment approaches appear reasonable.
The team may request further information, seek another specialist opinion, or document more than one reasonable option. The uncertainty should then be explained to the patient.
No. You have the right to ask questions, consider alternatives, and obtain another opinion. Treatment should proceed only after informed consent.
Yes. Ask your treating doctor whether multidisciplinary review would add value and whether the hospital has a tumor board for your type of cancer.
A tumor board is a structured meeting where different cancer specialists think together.
Its value lies in connecting the biopsy, scans, stage, tumor biology, surgical considerations, treatment options, and patient preferences into one coordinated plan.
In my Bengaluru practice, I often see how much clarity patients gain when they understand not only what treatment is recommended, but also why it should be given in a particular sequence.
If your case is being discussed at a tumor board, ask what question the team is trying to answer and when the recommendation will be explained to you. If it has not been discussed, you may ask whether multidisciplinary review would add meaningful value.
Online information can help you prepare for a consultation, but it cannot determine the right treatment for an individual patient. Your plan should be based on a careful review of your diagnosis, stage, overall health, treatment goals, and personal priorities.
Written by: Dr. Suraj Manjunath
Senior Consultant Surgical Oncologist, Bangalore
MBBS, MS, MCh – Surgical Oncology
25+ years of experience in surgical oncology
12,000+ cancer surgeries performed
20,000+ patients treated
Former Professor and HOD, Surgical Oncology
This article has been written and medically reviewed under the guidance of Dr. Suraj Manjunath, Senior Surgical Oncologist in Bangalore. Dr. Suraj Manjunath has over 25 years of experience in the surgical treatment of cancers involving the gastrointestinal tract, breast, gynecological organs, head and neck region, thoracic organs, urologic system, endocrine glands, soft tissue, and bone.
He has extensive experience in open cancer surgery, robotic cancer surgery, laparoscopic cancer surgery, thoracoscopic cancer surgery, cytoreductive surgery, and HIPEC. His clinical focus is on safe cancer clearance, individualized surgical planning, complication prevention, and structured recovery after major cancer operations.
The content is intended for patient education and should not replace a personalized consultation with a qualified surgical oncologist.
Medically reviewed by: Dr. Suraj Manjunath
Senior Consultant Surgical Oncologist, Bangalore
Date Published:
Date Reviewed: